Evidence map›Paper›PMID 38929727›Full record

ArticleLife (Basel, Switzerland)2024

Preliminary External Validation Results of the Artificial Intelligence-Based Headache Diagnostic Model: A Multicenter Prospective Observational Study.

Mariko Okada, Masahito Katsuki, Tomokazu Shimazu, Takao Takeshima, Takashi Mitsufuji, Yasuo Ito, Katsumi Ohbayashi, Noboru Imai, Junichi Miyahara, Yasuhiko Matsumori and 4 more

Abstract read
In one paragraph

Article in Life (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Mariko OkadaDepartment of Neurology, Saitama Medical University, 38 Morohongo, Moroyama-machi, Iruma-gun, Saitama 350-0495, Japan.
Masahito KatsukiPhysical Education and Health Center, Nagaoka University of Technology, Niigata 940-2137, Japan.ORCID 0000-0002-0192-5430
Tomokazu ShimazuDepartment of Neurology, Saitama Neuropsychiatric Institute, Saitama 338-8577, Japan.ORCID 0000-0001-9146-7770
Takao TakeshimaHeadache Center and Department of Neurology, Tominaga Hospital, Osaka 556-0017, Japan.ORCID 0000-0003-2678-6956
Takashi MitsufujiDepartment of Neurology, Saitama Medical University, 38 Morohongo, Moroyama-machi, Iruma-gun, Saitama 350-0495, Japan.
Yasuo ItoDepartment of Neurology, Saitama Medical University, 38 Morohongo, Moroyama-machi, Iruma-gun, Saitama 350-0495, Japan.ORCID 0000-0003-4434-1977
Katsumi OhbayashiOhbayashi Clinic, Tochigi 321-0933, Japan.
Noboru ImaiDepartment of Neurology, Japanese Red Cross Shizuoka Hospital, Shizuoka 420-0853, Japan.ORCID 0000-0002-8745-0391
Junichi MiyaharaHeadache Center and Department of Neurology, Tominaga Hospital, Osaka 556-0017, Japan.
Yasuhiko MatsumoriSendai Headache and Neurology Clinic, Sendai 982-0014, Japan.
Yoshihiko NakazatoDepartment of Neurology, Saitama Medical University, 38 Morohongo, Moroyama-machi, Iruma-gun, Saitama 350-0495, Japan.
Kazuki FujitaDepartment of Neurology, Jichi Medical University Saitama Medical Center, Saitama 330-8503, Japan.
Eri HoshinoDepartment of Neurology, Saitama Neuropsychiatric Institute, Saitama 338-8577, Japan.
Toshimasa YamamotoDepartment of Neurology, Saitama Medical University, 38 Morohongo, Moroyama-machi, Iruma-gun, Saitama 350-0495, Japan.ORCID 0009-0005-1171-6244

Funding

Saitama Medical University 22-E-1-03
6 · The paper itself

Abstract

The misdiagnosis of headache disorders is a serious issue, and AI-based headache model diagnoses with external validation are scarce. We previously developed an artificial intelligence (AI)-based headache diagnosis model using a database of 4000 patients' questionnaires in a headache-specializing clinic and herein performed external validation prospectively. The validation cohort of 59 headache patients was prospectively collected from August 2023 to February 2024 at our or collaborating multicenter institutions. The ground truth was specialists' diagnoses based on the initial questionnaire and at least a one-month headache diary after the initial consultation. The diagnostic performance of the AI model was evaluated. The mean age was 42.55 ± 12.74 years, and 51/59 (86.67%) of the patients were female. No missing values were reported. Of the 59 patients, 56 (89.83%) had migraines or medication-overuse headaches, and 3 (5.08%) had tension-type headaches. No one had trigeminal autonomic cephalalgias or other headaches. The models' overall accuracy and kappa for the ground truth were 94.92% and 0.65 (95%CI 0.21-1.00), respectively. The sensitivity, specificity, precision, and F values for migraines were 98.21%, 66.67%, 98.21%, and 98.21%, respectively. There was disagreement between the AI diagnosis and the ground truth by headache specialists in two patients. This is the first external validation of the AI headache diagnosis model. Further data collection and external validation are required to strengthen and improve its performance in real-world settings.

Indexed as

artificial intelligence (AI)digital transformation (DX)efficient medicineheadachemachine learningmedication-overuse headachemigrainerural areaspecialist

Identifiers

PMID38929727
PMCPMC11204521

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.